A study by Obradović et al., (2019) revealed an increase in the levels stress hormone during breast cancer progression that causes an increased activity of the glucocorticoid receptor (GR) at distant metastatic sites, and ultimately reducing the survival rate [292]. The gene discussed is NR3C1; the disease is breast carcinoma.